Thrombosis
Thrombosis is the formation of blood clot in the blood vessel. Thrombosis is generally classified by the type of blood vessel affected and the precise location of the blood vessels or the organ supplied by it. The treatment of thrombosis depends on the type of blood vessel whether it is in a vein or an artery, person’s impact and the risk of complications from treatment.
Thrombosis is classified into 3 types:
- Venous thrombosis
- Arterial thrombosis
- Limb ischemia
Related Conference of Thrombosis
Thrombosis Conference Speakers
Recommended Sessions
- Anemia
- Biomarkers in Haematology and Oncology
- Blood Products
- Blood Tests
- Blood Transfusion
- Case reports and Epidemiology of Hematology & Hem-Oncology
- Haematology and Pharma industry
- Hematology Nursing
- Hemochromatosis
- HIV/AIDS
- Immunohematology
- Leukocytosis
- Lymphoma
- Myeloma
- Pediatric Haematology
- Stem Cell Therapy
- Thrombocytopenia
- Thrombosis
Related Journals
Are you interested in
- Advances in Hematologic Malignancies - Blood Disorders 2025 (France)
- Advances in Hemostasis and Thrombosis - Blood Disorders 2025 (France)
- Biomarkers in Hematology and Oncology - Hematology Congress 2025 (Switzerland)
- Blood Disorders and the Immune System - Blood Disorders 2025 (France)
- Blood Disorders in Aging Populations - Blood Disorders 2025 (France)
- Blood Disorders: Diagnosis and Treatment - Hematology Congress 2025 (Switzerland)
- Cancer Genomics & Metabolomics - Hematology Congress 2025 (Switzerland)
- Case Reports in Hematology - Hematology Congress 2025 (Switzerland)
- Clinical Haematology - Hematology Congress 2025 (Switzerland)
- Cord Blood Transplantation - Hematology Congress 2025 (Switzerland)
- Cutting-Edge Research in Blood Disorders - Blood Disorders 2025 (France)
- Digital Imaging in Hematology - Hematology Congress 2025 (Switzerland)
- Future Trends in Hematology: Artificial Intelligence and Big Data - Blood Disorders 2025 (France)
- Gene Therapy and Genetic Engineering in Hematology - Blood Disorders 2025 (France)
- Haematology and Pharma Industry - Hematology Congress 2025 (Switzerland)
- Hematologic Cancers - Hematology Congress 2025 (Switzerland)
- Hematologic Toxicities and Side Effects of Cancer Therapy - Blood Disorders 2025 (France)
- Hematology and Cardio-Oncology - Hematology Congress 2025 (Switzerland)
- Hematology in Global Health: Addressing Disparities - Blood Disorders 2025 (France)
- Hematology Nursing - Hematology Congress 2025 (Switzerland)
- Hematology: Diagnostics and Screening - Hematology Congress 2025 (Switzerland)
- Hematopoietic Malignancies - Hematology Congress 2025 (Switzerland)
- Immunohematology - Hematology Congress 2025 (Switzerland)
- Immunotherapy and Cellular Therapies in Hematology - Blood Disorders 2025 (France)
- Innovations in Red Blood Cell Disorders - Blood Disorders 2025 (France)
- Neuro-Hematology - Hematology Congress 2025 (Switzerland)
- Novel Diagnostic Techniques and Biomarkers in Hematology - Blood Disorders 2025 (France)
- Organ Specific Cancer - Hematology Congress 2025 (Switzerland)
- Pediatric Hematology - Hematology Congress 2025 (Switzerland)
- Pediatric Hematology: Challenges and Innovations - Blood Disorders 2025 (France)
- Stem Cell Therapy - Hematology Congress 2025 (Switzerland)
- Stem Cell Transplantation and Regenerative Medicine - Blood Disorders 2025 (France)
- Transfusion Medicine: Advances and Challenge - Blood Disorders 2025 (France)
- Transfusion Medicines - Hematology Congress 2025 (Switzerland)
- Vascular Bleeding Disorders - Hematology Congress 2025 (Switzerland)